Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Fish oil pills may boost attention in ADHD children, small study hints

NCT ID NCT07521449

Symptom relief Sponsor: Çağlar Charles Daniel Jaicks Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether phosphatidylserine supplements with or without DHA (an omega-3 fat) could improve thinking skills in children with ADHD. 45 children aged 10-14 who had never taken ADHD medication took either a placebo or one of three supplement formulas daily for 8 weeks. Researchers measured attention, impulsivity, and hyperactivity using computer tests before and after the treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Phosphatidylserine and DHA (omega-3) supplements
What this could lead to
If it works, this could point toward a natural supplement option to help children with ADHD focus better without medication.
What could go wrong
This is a small, early-stage trial with only 45 children. The results may not apply to all kids with ADHD, and supplements are not a substitute for proven treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

45 people

The number who actually took part.

Started

Dec 2023

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

10 to 14 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children aged 10-14 years * Diagnosis of ADHD according to DSM-5 criteria or clinically significant subthreshold ADHD symptoms * Medication-naïve status * Ability to complete cognitive assessments (MOXO d-CPT and Stroop test) * Informed consent obtained from parents or legal guardians Exclusion Criteria: * Presence of psychiatric disorders requiring pharmacological treatment (e.g., major depressive disorder, severe anxiety disorders, autism spectrum disorder) * Neurological or sensory impairments affecting test performance * Use of cognitive-enhancing supplements (e.g., omega-3, phosphatidylserine, citicoline) within the previous 8 weeks * Severe ADHD requiring immediate pharmacological treatment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADHD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADHD Attention deficit hyperactivity disorder (ADHD)

Contacts and locations

Locations

  • Istanbul Aydin University, Department of Child and Adolescent Psychiatry, Istanbul, Turkey

    Istanbul, Istanbul, 34295, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.